BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10118005)

  • 1. CFOs and strategists: forging a common framework.
    Rappaport A
    Harv Bus Rev; 1992; 70(3):84-91. PubMed ID: 10118005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10 ways to create shareholder value.
    Rappaport A
    Harv Bus Rev; 2006 Sep; 84(9):66-77, 155. PubMed ID: 16967621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CEO as organizational architect: an interview with Xerox's Paul Allaire. Interview by Robert Howard.
    Allaire P
    Harv Bus Rev; 1992; 70(5):106-21. PubMed ID: 10121313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competing on capabilities: the new rules of corporate strategy.
    Stalk G; Evans P; Shulman LE
    Harv Bus Rev; 1992; 70(2):57-69. PubMed ID: 10117369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capital disadvantage: America's failing capital investment system.
    Porter ME
    Harv Bus Rev; 1992; 70(5):65-82. PubMed ID: 10121317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divestiture: strategy's missing link.
    Dranikoff L; Koller T; Schneider A
    Harv Bus Rev; 2002 May; 80(5):74-83, 133. PubMed ID: 12024760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative value of growth.
    Mass NJ
    Harv Bus Rev; 2005 Apr; 83(4):102-12, 134. PubMed ID: 15807043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The competitive advantage of corporate philanthropy.
    Porter ME; Kramer MR
    Harv Bus Rev; 2002 Dec; 80(12):56-68, 133. PubMed ID: 12510538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The case of the combative CFO.
    Nichols NA; Bagley CE; Beard E; Dworkin D; Millstein IM
    Harv Bus Rev; 1992; 70(4):14-6, 20-1, 24. PubMed ID: 10119718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. If private equity sized up your business.
    Pozen RC
    Harv Bus Rev; 2007 Nov; 85(11):78-87, 152. PubMed ID: 18159788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing for value. It's not just about the numbers.
    Haspeslagh P; Noda T; Boulos F
    Harv Bus Rev; 2001; 79(7):64-73, 144. PubMed ID: 11447618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The "barbarians" in the boardroom.
    Anders G
    Harv Bus Rev; 1992; 70(4):79-87. PubMed ID: 10119720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The myth of Japan's low-cost capital.
    Kester WC; Luehrman TA
    Harv Bus Rev; 1992; 70(3):130-8. PubMed ID: 10118000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Executive compensation in excess of $1 million: shareholder approval and corporate waste.
    Kaderabek LM; Quinlan WJ
    Benefits Q; 1995; 11(3):96-101. PubMed ID: 10151121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creating corporate advantage.
    Collis DJ; Montgomery CA
    Harv Bus Rev; 1998; 76(3):70-83. PubMed ID: 10179655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profit pools: a fresh look at strategy.
    Gadiesh O; Gilbert JL
    Harv Bus Rev; 1998; 76(3):139-47. PubMed ID: 10179649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The link between benchmarking and shareholder value.
    Schmidt JA
    J Bus Strategy; 1992; 13(3):7-13. PubMed ID: 10124958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Making real options really work.
    van Putten AB; MacMillan IC
    Harv Bus Rev; 2004 Dec; 82(12):134-41, 150. PubMed ID: 15605572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The staying power of the public corporation.
    Rappaport A
    Harv Bus Rev; 1990; 68(1):96-104. PubMed ID: 10103814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond takeovers: politics comes to corporate control.
    Pound J
    Harv Bus Rev; 1992; 70(2):83-93. PubMed ID: 10117371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.